Subhash Kapre

Chief Executive Officer, Inventprise LLC

Subhash established Inventprise in 2012 with the aim of developing cheaper, safer vaccines. A previous board member of the Serum Institute of India, he has over 44 years of experience in research and development. Under a project grant from the Bill & Melinda Gates Foundation, Inventprise has created a liquid heat-stable Rota virus vaccine that can withstand temperatures of 50°C for 5 months.

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019